Affiliations 

  • 1 Department of Second Gynecology, Cangzhou Central Hospital, Cangzhou, Hebei Province, People's Republic of China
  • 2 Department of Endocrinology, The Fourth People's Hospital of Jinan City, Tianqiao District, Jinan, Shandong Province, People's Republic of China
  • 3 School of Bioprocess Engineering, Universiti Malaysia Perlis, Arau, Perlis, 02600, Malaysia
  • 4 Department of Oral & Craniofacial Sciences, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia
  • 5 Department of Gynecology Endocrinology, Maternal and Child Health Care of Shandong Province, Jinan, Shandong Province, People's Republic of China
Biotechnol Appl Biochem, 2021 Aug;68(4):881-888.
PMID: 33245588 DOI: 10.1002/bab.2008

Abstract

17β-Estradiol-E2 (17β-E2) is a steroid hormone that plays a major role in the reproductive endocrine system and is involved in various processes, such as pregnancy, fertility, and menopause. In this study, the performance of an enzyme-linked immunosorbent assay (ELISA) for 17β-E2 quantification was enhanced by using a gold nanoparticle (GNP)-conjugated aptamer. An anti-17β-E2-aptamer-GNP antibody was immobilized on an amine-modified ELISA surface. Then, 17β-E2 was allowed to interact with and be sandwiched by antibodies. Aptamer-GNP conjugation was confirmed by colorimetric assays via the naked eye and UV-visible light spectroscopy. The detection limit based on a signal-to-noise ratio (S/N) of 3 was estimated to be 1.5 nM (400 pg/mL), and the linear range was 1.5-50 nM. Control experiments (without 17β-E2/with a complementary aptamer sequence/with a nonimmune antibody) confirmed the specific detection of 17β-E2. Moreover, 17β-E2 spiking of human serum did not interrupt the interaction between 17β-E2 and its antibody and aptamer. Thus, the developed ELISA can be used as an alternate assay for quantification of 17β-E2 and assessment of endocrine-related gynecological problems.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.